Product Information
CLEMASTINE FUM 2.68 MG TABLET is a generic product labeled by Genus Lifesciences Inc., priced at $3.1775 per EA under NDC 64950026810. Its NADAC has been published 66 times since Mar 12, 2025.
FDA first approved this application on Jan 31, 1992.
Strength
2.68 mg/1
Manufacturer
Genus Lifesciences Inc.NDC
64950026810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLEMASTINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA073283FDA Approved
1/31/1992
On Market Since
11/20/2024
Price Statistics
The NADAC for CLEMASTINE FUM 2.68 MG TABLET has been published 66 times since Mar 12, 2025, and over the history we have for it it has risen 534.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1775 per EA |
|---|---|
| All-time high | $3.3560 (Apr 15, 2026) |
| All-time low | $0.5009 (Mar 12, 2025) |
| 52-week high | $3.3560 |
| 52-week low | $3.1775 |
| Median price | $3.2039 |
| Average price | $2.0739 |
| Largest weekly change | +563.4% (Jan 21, 2026) |
| Weeks tracked | 66 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genus Lifesciences Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clemastine Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLEMASTINE FUM 2.68 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLEMASTINE FUM 2.68 MG TABLET, manufactured by Genus Lifesciences Inc., is $3.1775 per EA (NDC 64950026810), effective Sep 30, 2026.
How has the price of CLEMASTINE FUM 2.68 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLEMASTINE FUM 2.68 MG TABLET has risen 534.4%. It has been tracked across 66 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for CLEMASTINE FUM 2.68 MG TABLET?
Since Mar 12, 2025, the NADAC for CLEMASTINE FUM 2.68 MG TABLET has ranged from a low of $0.5009 (Mar 12, 2025) to a high of $3.3560 (Apr 15, 2026), with a median of $3.2039 per EA.
Are there cheaper alternatives to CLEMASTINE FUM 2.68 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLEMASTINE FUM 2.68 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLEMASTINE FUM 2.68 MG TABLET?
CLEMASTINE FUM 2.68 MG TABLET (NDC 64950026810) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.